View the Show Notes Page for This Episode
Become a Member to Receive Exclusive Content
Sign Up to Receive Peter’s Weekly Newsletter
Max Diehn is a Professor of Radiation Oncology at Stanford and a clinical radiation oncologist specializing in lung cancer. Max’s research focuses on developing novel methods for detecting circulating tumor DNA in the blood of cancer patients and on elucidating the molecular pathways and genes associated with cancer. His interests also include uncovering biomarkers that can predict patient survival, responses to therapy, and disease recurrence. In this packed episode, Max discusses the history of blood-based cancer screening and the importance of understanding the predictive value of tests—sensitivity, specificity, negative predictive value, positive predictive value – and how these metrics play into cancer screening. Max then goes in depth on the topic of liquid biopsies, including the history, current landscape, and possible future of liquid biopsies as a cancer detection tool. He discusses how these non-invasive blood tests can detect DNA/RNA from tumor cells released into the blood as well as the different methods one can use to predict if a cancer is present. He gets granular on the topic of cell-free DNA/RNA signature, methylation patterns, and the importance of knowing mutation information, and he ends with a discussion on the exciting future of liquid biopsies and how we can possibly get to the panacea of cancer screening.
We discuss:
Connect With Peter on Twitter, Instagram, Facebook and YouTube
A masterclass on insulin resistance—mechanisms and implications | Gerald Shulman, M.D., Ph.D. (#140 rebroadcast)
#231 - AMA #41: Medicine 3.0, developments in the field of aging, healthy habits in times of stress, and more
#230 ‒ Cardiovascular disease in women: prevention, risk factors, lipids, and more | Erin Michos, M.D.
#229 ‒ Understanding cardiovascular disease risk, cholesterol, and apoB
#228 ‒ Improving body composition, female-specific training principles, and overcoming an eating disorder | Holly Baxter, APD
#227 - AMA #40: Body composition, protein, time-restricted feeding, fasting, DEXA scans, and more
#226 ‒ The science of happiness | Arthur Brooks, Ph.D.
#225 ‒ The comfort crisis, doing hard things, rucking, and more | Michael Easter, MA
#224 ‒ Dietary protein: amount needed, ideal timing, quality, and more | Don Layman, Ph.D.
#223 - AMA #39: The Centenarian Decathlon, zone 2, VO2 max, and more
#222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D
#221 ‒ Understanding sleep and how to improve it
#220 ‒ Ketamine: Benefits, risks, and promising therapeutic potential | Celia Morgan, Ph.D.
#219 ‒ Dialectical behavior therapy (DBT): skills for overcoming depression , emotional dysregulation, and more | Shireen Rizvi, Ph.D., ABPP
#218 - AMA #38: Can you exercise too much?
#217 ‒ Exercise, VO2 max, and longevity | Mike Joyner, M.D.
#216 - Metabolomics, NAD+, and cancer metabolism | Josh Rabinowitz, M.D., Ph.D.
#215 - The gut-brain connection | Michael Gershon, M.D.
#214 - AMA #37: Bone health—everything you need to know
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Huberman Lab
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.